Central Ohio’s top individual finishers in the Division I state tournament and five members of the three qualifying teams ...

Taxpayers are suing Arrowhead Union High School District officials, alleging misrepresentation in referendum information of renovation costs. The lawsuit claims the district has repeatedly sought ...

Check out how we test and review games here At the Game Developers Conference 2025, Arrowhead CCO, Johan Pilestedt, discussed the ironic and self-aware tone of Helldivers 2. As relayed by PC Gamer ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Karel Arrowhead, initially labelled as Sleeping Man in-game is an NPC in the Kuttenberg region of KCD2. However, he is only available to meet as a random event after the Speak of the Devil main ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...

H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line data from Part 2 of the Phase 1/2 trial evaluating ...